Neuberg Diagnostics has secured Rs 940 crore from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector. 

Founded in 2017 and headquartered in Chennai, Neuberg Diagnostics has rapidly emerged as the fastest-growing, largest integrated diagnostics player in the country and one of the top 4 largest diagnostics providers of Indian origin.

With an extensive network spanning over 10,000 touch points and 250+ labs across 250 cities, the company is well on its way to transforming the healthcare landscape in India.

It boasts a highly skilled team of clinical pathologists, oncopathologists, biochemists, geneticists, and other certified lab professionals, giving it the capability to perform over 5,000 types of tests. 

Speaking about the fundraise, Dr GSK Velu, Founder and MD of Neuberg Diagnostics, said, “This funding will enable us to enhance our capabilities in the areas of personalised medicine, integrated diagnostics and inorganically expand our footprint across the country. As we prepare for an IPO, we remain committed to making high-quality diagnostics accessible to all, ensuring that our services continue to meet the evolving needs of clinicians and patients.”

Rahul Shah, Partner at Kotak Alt said, “We are confident that this strategic investment will play a key role in increasing the scale of Neuberg Diagnostics and help the company get ready for their upcoming IPO." 

o3 Capital acted as the exclusive financial advisor to Neuberg Diagnostics for their fundraise from Kotak Alt.